SOLANA BEACH, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases ...
FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025Gimoti remains only approved drug shown to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback